LAM
INFI

Lebenthal Asset Management’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

Lebenthal Asset Management’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-700
Closed -$1K – 731
2016
Q3 		$1K Buy
+700
New +$1.07K ﹤0.01% 957

Other funds holding INFI

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Lebenthal Asset Management's INFI Position: Q4 2016 in Review

Lebenthal Asset Management sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q4 2016, closing a stake of 700 shares — an estimated $1K sold.

Lebenthal Asset Management first reported a position in INFI in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 94 funds tracked by Wall St. Rank hold INFI as of Q4 2016.

  • Lebenthal Asset Management reported no remaining Infinity Pharmaceuticals, Inc. position as of Q4 2016 after selling out during the quarter.
  • Lebenthal Asset Management sold 700 Infinity Pharmaceuticals, Inc. shares in Q4 2016, an estimated $1K.
  • Lebenthal Asset Management first reported a position in Infinity Pharmaceuticals, Inc. in Q3 2016 and held it in 1 quarter.
  • Lebenthal Asset Management's Infinity Pharmaceuticals, Inc. position peaked at $1K in Q3 2016.
  • 94 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q4 2016.

Based on Lebenthal Asset Management's 13F filing for Q4 2016, filed 15 Feb 2017.